-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AjdoEfQD72htusyT95KfsEgRLZP+EIBX8i6sv1Plzu+aJBrRIglAix4IkACCwSTA JBC374kxgR2MSrh+GQ9nCA== 0000810084-08-000013.txt : 20080311 0000810084-08-000013.hdr.sgml : 20080311 20080311214204 ACCESSION NUMBER: 0000810084-08-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080308 FILED AS OF DATE: 20080311 DATE AS OF CHANGE: 20080311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000810084 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931099680 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20245 SW 95TH AVENUE CITY: TUALATIN STATE: OR ZIP: 97062 BUSINESS PHONE: 5036928001 MAIL ADDRESS: STREET 1: 20245 SW 95TH AVENUE CITY: TUALATIN STATE: OR ZIP: 97062 FORMER COMPANY: FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FARRELL CHRISTINE CENTRAL INDEX KEY: 0001200160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 08682234 BUSINESS ADDRESS: STREET 1: 211 SOMERVILLE RD 202N CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 9087192244 MAIL ADDRESS: STREET 1: 8405 B SW CURRY DR CITY: WILSONVILLE STATE: OR ZIP: 97070 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2008-03-08 0 0000810084 BIOJECT MEDICAL TECHNOLOGIES INC BJCT 0001200160 FARRELL CHRISTINE 20245 SW 95TH AVENUE TUALATIN OR 97062 0 1 0 0 VP of Finance BJCT Common Stock 2008-03-08 4 M 0 25000 0 A 66109 D BJCT Common Stock 2008-03-10 4 M 0 500 0 A 66609 D BJCT Common Stock 14291 I 401K Restricted Stock Unit 2008-03-08 4 M 0 25000 0 D 2008-03-08 BJCT Common Stock 25000 249130 D Restricted Stock Unit 2008-03-10 4 M 0 500 0 D 2008-03-10 BJCT Common Stock 500 248630 D Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock. 50% vesting 3/8/2008 pursuant to 3/8/2007 Restricted Stock Unit Incentive Agreement. Includes Series F Preferred Stock 10,100, Warrant (right-to-buy) 1,000, Option (right-to-buy) 64,696 Restricted Stock Unit 172,834 (Includes 18,000 Restricted Stock Units canceled due to performance metrics). Christine M. Farrell 2008-03-11 -----END PRIVACY-ENHANCED MESSAGE-----